Coutinho Maria Francisca, Alves Sandra
Research and Development Unit, Department of Human Genetics, INSA, Portugal.
Research and Development Unit, Department of Human Genetics, INSA, Portugal.
Mol Genet Metab. 2016 Feb;117(2):53-65. doi: 10.1016/j.ymgme.2015.08.008. Epub 2015 Aug 18.
Sixty years after its discovery, the lysosome is no longer considered as cell's waste bin but as an organelle playing a central role in cell metabolism. Besides its well known association with lysosomal storage disorders (mostly rare and life-threatening diseases), recent data have shown that the lysosome is also a player in some of the most common conditions of our time; and, perhaps even most important, it is not only a target for orphan drugs (rare disease therapeutic approaches) but also a putative target to treat patients suffering from common complex diseases worldwide. Here we review the striking associations linking rare lysosomal storage disorders such as the well-known Gaucher disease, or even the recently discovered, extremely rare Neuronal Ceroid Lipofuscinosis-11 and some of the most frequent, multifaceted and complex disorders of modern society such as cancer, Parkinson's disease and frontotemporal lobar degeneration.
在溶酶体被发现60年后,它不再被视为细胞的垃圾桶,而是在细胞代谢中发挥核心作用的细胞器。除了其与溶酶体贮积症(大多为罕见且危及生命的疾病)的众所周知的关联外,最近的数据表明,溶酶体在我们这个时代的一些最常见病症中也发挥作用;而且,也许甚至最重要的是,它不仅是孤儿药(罕见病治疗方法)的靶点,也是治疗全球患有常见复杂疾病患者的一个假定靶点。在此,我们综述了罕见的溶酶体贮积症(如著名的戈谢病,甚至是最近发现的极其罕见的神经元蜡样脂褐质沉积症11型)与现代社会一些最常见、多方面且复杂的病症(如癌症、帕金森病和额颞叶痴呆)之间的显著关联。